{
  "pmid": "36372068",
  "uid": "36372068",
  "title": "Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel C",
      "initials": "HC",
      "name": "Hertzel C Gerstein",
      "affiliations": [
        "Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON L8S 4K1, Canada. Electronic address: gerstein@mcmaster.ca."
      ]
    },
    {
      "last_name": "Sattar",
      "fore_name": "Naveed",
      "initials": "N",
      "name": "Naveed Sattar",
      "affiliations": [
        "School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK."
      ]
    }
  ],
  "journal": {
    "title": "The lancet. Diabetes & endocrinology",
    "iso_abbreviation": "Lancet Diabetes Endocrinol",
    "issn": "2213-8595",
    "issn_type": "Electronic",
    "volume": "10",
    "issue": "12",
    "pub_year": "2022",
    "pub_month": "Dec"
  },
  "start_page": "831",
  "end_page": "832",
  "pages": "831-832",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Comment"
  ],
  "keywords": [
    "Humans",
    "Sodium-Glucose Transporter 2 Inhibitors",
    "Hypoglycemic Agents",
    "Heart Failure"
  ],
  "article_ids": {
    "pubmed": "36372068",
    "doi": "10.1016/S2213-8587(22)00313-8",
    "pii": "S2213-8587(22)00313-8"
  },
  "doi": "10.1016/S2213-8587(22)00313-8",
  "dates": {
    "completed": "2022-11-29",
    "revised": "2022-12-15"
  },
  "chemicals": [
    "Sodium-Glucose Transporter 2 Inhibitors",
    "Hypoglycemic Agents"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:22:49.739992",
    "pmid": "36372068"
  }
}